Skip to main content
Clinical Trials/JPRN-UMIN000049216
JPRN-UMIN000049216
Completed
未知

Verification of impacts on brain activity, by test-food intake in a single dose - Verification of impacts on brain activity, by test-food intake in a single dose

CPCC Company Limited0 sites24 target enrollmentOctober 18, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy male/female adults
Sponsor
CPCC Company Limited
Enrollment
24
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 18, 2023
End Date
November 18, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
CPCC Company Limited

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Volunteers being under some kind of continuous medical treatment, including the test period. (2\) Volunteers who have periodically used health\-specific / functional / health foods including supplements, which might affect the autonomic nervous system, metabolism and sleep. (3\) Volunteers with incompatible chest (e.g., thick bodyhair, pacemaker\-fitting) for heartbeat measurements. (4\) Volunteers with excessive alcohol intake (not less than 60 g/day/week). (5\) Volunteers with extremely irregular eating habits, and volunteers having an irregular life rhythm with irregular shift work or midnight one. (6\) At the moment of informed consent, volunteers who are under other clinical tests with some kind of medicine/food, or partook in those within four weeks before the current study, or are planning to take part in those after the consent. (7\) Volunteers who are under a large stress condition with some kind of life event, such as house\-moving, transfer, bereavement, etc., within three months before the agreement for this study and during the test period. (8\) Volunteers with any difficulty in giving up drinking since the day before the scheduled date of this study. (9\) Volunteers with previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs. (10\) Volunteers getting excessive exercise every day. (11\) Volunteers with a serious symptom of premenstrual syndrome. (12\) Volunteers who have been determined as poor blood circulation, according to the doctor's oral questions at the moment of informed consent. (13\) Volunteers planning to vaccinate within three days before this study. (14\) Pregnant, possibly pregnant, and lactating women. (15\) Volunteers having some kind of drug and/or food allergy. (16\) Volunteers who break out in a rash from putting electrodes on the head and chest. (17\) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.

Outcomes

Primary Outcomes

Not specified

Similar Trials